Jpmorgan Healthcare Leaders ETF Rating $54.92 -0.13 (-0.24%) (As of 11/18/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatings Jpmorgan Healthcare Leaders ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.JDOC Aggregate RatingModerate Buy 2.77Holdings in JDOC have an aggregate rating of Moderate Buy based on 659 analyst ratings issued in the past year covering 37 companies (74.0% of the portfolio).JDOC Aggregate Price Target$54.92High Prediction$54.92Average Prediction$54.92Low Prediction$54.92Holdings in JDOC have an aggregate price target of $54.92 and a range of $54.92 to $54.92 covering 37 companies (74.0% of the portfolio).JDOC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy29 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Jpmorgan Healthcare Leaders ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 37 JDOC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.05%LLYEli Lilly and Company$727.57-2.5%4.9925 of 5 stars2.81$1,007.94 38.5%21Ex-DividendAnalyst ForecastPositive NewsHigh Trading Volume7.98%UNHUnitedHealth Group$589.65-0.4%4.9295 of 5 stars2.95$615.53 4.4%22Analyst RevisionPositive News5.24%ABBVAbbVie$166.26+0.8%4.9617 of 5 stars2.90$203.89 22.6%21Analyst ForecastShort Interest ↑4.59%TMOThermo Fisher Scientific$501.50-2.3%4.9918 of 5 stars2.86$649.33 29.5%22Buyback AnnouncementAnalyst RevisionPositive NewsHigh Trading Volume3.82%DHRDanaher$229.50-0.4%4.9884 of 5 stars2.74$287.16 25.1%19Positive News3.60%REGNRegeneron Pharmaceuticals$762.00+0.7%4.8029 of 5 stars2.78$1,099.55 44.3%23Analyst ForecastPositive News3.23%BSXBoston Scientific$90.45+4.0%4.6036 of 5 stars2.91$93.39 3.3%23Analyst ForecastShort Interest ↑Gap Up2.58%MDTMedtronic$87.64+0.1%4.8569 of 5 stars2.41$95.80 9.3%17Upcoming EarningsAnalyst ForecastPositive News2.55%SYKStryker$389.40-0.2%4.95 of 5 stars2.80$393.65 1.1%20Positive News2.55%VRTXVertex Pharmaceuticals$467.01+0.3%3.5332 of 5 stars2.53$499.12 6.9%30Positive News2.44%JNJJohnson & Johnson$154.77+0.5%4.9651 of 5 stars2.53$175.94 13.7%15Analyst ForecastPositive News2.32%MCKMcKesson$615.61+1.5%4.7919 of 5 stars2.94$631.57 2.6%16Positive News2.29%CIThe Cigna Group$322.40+0.3%4.976 of 5 stars3.00$394.64 22.4%15Short Interest ↑2.25%BMYBristol-Myers Squibb$56.81+1.0%4.7816 of 5 stars2.20$54.07 -4.8%20Analyst ForecastAnalyst Revision1.68%MRKMerck & Co., Inc.$96.56+0.3%4.9979 of 5 stars2.68$130.86 35.5%19Analyst ForecastPositive News1.65%HCAHCA Healthcare$335.89-2.1%4.974 of 5 stars2.84$385.00 14.6%19Short Interest ↓1.56%ISRGIntuitive Surgical$531.64+0.8%4.6968 of 5 stars2.67$524.61 -1.3%18Short Interest ↑Positive News1.23%EXASExact Sciences$49.54+0.4%4.8884 of 5 stars2.95$74.47 50.3%19Short Interest ↓1.20%IQVIQVIA$191.19-0.8%4.9843 of 5 stars2.84$259.13 35.5%19Positive NewsHigh Trading Volume0.90%WSTWest Pharmaceutical Services$307.22-2.3%4.9767 of 5 stars2.67$460.33 49.8%3Analyst Revision0.88%CNCCentene$58.83+2.4%4.9665 of 5 stars2.50$83.92 42.7%14Analyst Revision0.81%COOCooper Companies$99.48-0.2%3.5079 of 5 stars2.75$117.00 17.6%12Short Interest ↑0.79%DXCMDexCom$76.27+0.5%4.9788 of 5 stars2.72$104.59 37.1%18Short Interest ↑Positive News0.74%NBIXNeurocrine Biosciences$117.62+0.2%4.9644 of 5 stars2.83$163.91 39.4%24Positive News0.73%ITCIIntra-Cellular Therapies$82.47-1.1%4.4168 of 5 stars2.85$97.23 17.9%13Positive News0.73%AMGNAmgen$278.76-0.9%4.9165 of 5 stars2.46$333.57 19.7%26Analyst ForecastShort Interest ↓0.73%INSPInspire Medical Systems$175.30+1.5%4.9138 of 5 stars2.67$227.75 29.9%12Gap Up0.66%HALOHalozyme Therapeutics$42.57-6.7%4.9815 of 5 stars2.60$61.11 43.6%10High Trading Volume0.66%NTRANatera$153.42+5.0%2.8449 of 5 stars3.00$140.59 -8.4%17Earnings ReportAnalyst ForecastInsider SellingAnalyst RevisionGap Up0.66%SRPTSarepta Therapeutics$104.67+0.1%4.961 of 5 stars3.00$181.33 73.2%220.63%HUMHumana$271.35-1.6%4.6824 of 5 stars2.24$315.86 16.4%25Short Interest ↑Analyst Revision0.62%AGIOAgios Pharmaceuticals$52.89-1.7%3.3235 of 5 stars2.50$52.33 -1.1%8Short Interest ↑0.55%BPMCBlueprint Medicines$90.18+1.7%2.9205 of 5 stars2.71$122.11 35.4%21Analyst ForecastShort Interest ↑0.54%BMRNBioMarin Pharmaceutical$61.93-2.3%4.989 of 5 stars2.74$94.20 52.1%23Analyst Forecast0.53%ACHCAcadia Healthcare$37.13-1.8%4.2719 of 5 stars2.60$83.33 124.4%10Analyst ForecastShort Interest ↑Analyst Revision0.52%TWSTTwist Bioscience$41.43+12.3%2.7601 of 5 stars2.67$51.22 23.6%9News CoverageGap UpHigh Trading Volume0.52%BHVNBiohaven$45.43+2.3%3.794 of 5 stars3.07$63.42 39.6%14Earnings Report This page (NYSEARCA:JDOC) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this ...Crypto 101 Media | SponsoredWhy Buffett, Bezos & Congress Are Rushing Into This SectorWhy are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s EPIC Stock Market RallyPutting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jpmorgan Healthcare Leaders ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Jpmorgan Healthcare Leaders ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
